Rega has been a long-standing customer of ZOLL for over 16 years, first using the ZOLL PD 1400 on emergency missions, and more recently equipping its helicopters and jets with the ZOLL M Series defibrillator.

The Propaq MD, which is 60% smaller and 40% lighter than similar monitor/defibrillators, comes with large, high-contrast color LCD display capable of showing up to four waveforms simultaneously, as well as a full 12-lead ECG for on-screen review, ZOLL Medical said.

All physiological monitoring parameter values, including heart rate, SpO2, ETCO2, respiration, non-invasive blood pressure, two temperatures and three invasive pressures, are shown in large color-coded numeric formats.

The device is capable of monitoring all patients, whether adult, pediatric or neonatal.

ZOLL Medical claims that the Propaq MD is the only FDA-cleared airworthy defibrillator to provide monitoring of three invasive pressures necessary for treating critical patients during long transports.

Rega is an independent, non-profit, privately operated foundation, which is under the supervision of the Swiss Federal Government.